Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.
Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.
复制标题
DOI:
10.1001/jamapsychiatry.2014.2427
复制
发表时间:
2015-03
期刊:
影响因子:
25.8
通讯作者:
Meyer JH
中科院分区:
文献类型:
--
作者:
Setiawan E;Wilson AA;Mizrahi R;Rusjan PM;Miler L;Rajkowska G;Suridjan I;Kennedy JL;Rekkas PV;Houle S;Meyer JH
The neuroinflammatory hypothesis of major depressive disorder (MDD) is supported by several main findings: First, in humans and animals, activation of the immune system causes sickness behaviors that present during a major depressive episode (MDE) such as low mood, anhedonia, anorexia and weight loss. Second, peripheral markers of inflammation are frequently reported in MDD. Third, neuroinflammatory illnesses are associated with high rates of MDE. However, a fundamental limitation of the neuroinflammatory hypothesis is a paucity of evidence for brain inflammation during MDE. To investigate whether microglial activation, an important aspect of neuroinflammation, is present during MDE, [18F]FEPPA positron emission tomography (PET) was applied to measure translocator protein total distribution volume (TSPO VT), an index of TSPO density. Translocator protein density is elevated in activated microglia. To determine whether TSPO VT, is elevated in the prefrontal cortex, anterior cingulate cortex (ACC) and insula in MDE secondary to MDD. Case-control study. Tertiary care psychiatric hospital. 20 subjects with MDE secondary to MDD and 20 healthy controls, underwent an [18F]FEPPA PET scan. MDE subjects were medication-free for at least 6 weeks. All participants were otherwise healthy, and non-smoking. TSPO VT was measured in the prefrontal cortex, ACC, and insula. In MDE, TSPO VT was significantly elevated in all brain regions examined (multivariate analysis of variance, F15,23=4.46, P=0.001).TSPO VT was increased, on average, by 30% in the prefrontal cortex, ACC and insula. In MDE, greater TSPO VT in the ACC correlated with greater depression severity (ACC: r=0.628, P=0.005). This finding provides the most compelling evidence to date for brain inflammation, and more specifically microglial activation, in MDE. This is important for improving treatment since it implies that therapeutics which reduce microglial activation should be promising for MDE. The correlation between higher ACC TSPO VT with severity of MDE is consistent with the concept that neuroinflammation in specific regions may contribute to sickness behaviors which overlap with the symptoms of MDE.